Search Orphan Drug Designations and Approvals
-
Generic Name: | idelalisib |
---|---|
Date Designated: | 10/15/2013 |
Orphan Designation: | Treatment of splenic marginal zone lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Gilead Sciences, Inc. 199 E. Blaine St Seattle, Washington 98102 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-